CurrentAnthemPolicy 09-600

Therapeutic Parenteral Drug Administration

Guidance on the use and documentation of therapeutic parenteral drug administration (intravenous, intramuscular, subcutaneous, intradermal) in dental settings, including indications, exclusions (cosmetic, sedative/anesthetic/reversal agents, sustained-release infiltration for long-acting surgical site pain control), and coding references (CDT D9610, D9612, D9613).

Policy Summary

PayerAnthem

PolicyTherapeutic Parenteral Drug Administration

Policy CodePolicy 09-600

Change TypeClarified (minor editorial refinements)

Effective DateJan 1, 2025

Next Review Date

Key ActionSubmit clinical chart notes/narrative explaining the rationale for the medication and include the name and dosage of the medication administered for benefit consideration.

SourceLink

POLICY UPDATE CHANGES

Minor editorial refinements to description, clinical indications, and references; intent unchanged.

3Referenced CDT codes

3Explicit exclusions listed

2Required documentation elements

Policy overview

Scope: Guidance on the use and documentation of therapeutic parenteral drug administration (intravenous, intramuscular, subcutaneous, intradermal) in dental settings, including indications, exclusions (cosmetic, sedative/anesthetic/reversal agents, sustained-release infiltration for long-acting surgical site pain control), and coding references (CDT D9610, D9612, D9613).

Subject: Therapeutic Parenteral Drug Administration (dental). This applies to therapeutic, non-cosmetic parenteral medication administration in dental practice and references CDT codes D9610, D9612 and D9613 for informational purposes. Exclusions include sedative/anesthetic/reversal agents, cosmetic use, and infiltration of sustained-release agents for long-acting surgical site pain control.

Policy metadata

Policy number09-600

Policy titleTherapeutic Parenteral Drug Administration

StatusCURRENT (Revised)

Effective date2025-01-01

Last review2024-11-05

Next review

Coverage stanceinformational

Confidence0.89

Clinical criteria and administrative requirements

Medical/Clinical Criteria and Administrative Requirements

Guidance and requirements for therapeutic parenteral drug administration in dental practice:

ALL of the following

Route of administration must be parenteral (intravenous, intramuscular, subcutaneous or intradermal).
Medication may be antibiotics, steroids, anti-inflammatory drugs or other therapeutic medications intended to improve surgical healing, reduce pain and/or infection.
Therapeutic parenteral administration is indicated when oral or topical administration is ineffective, impractical, or too slow.
Clinical chart notes and narrative may be requested to explain the rationale for the medication.
Chart notes may be requested as administrative documentation.
Exclusions (NOT appropriate to report as therapeutic parenteral drug administration)
- Administration of sedative, anesthetic or reversal agents.
  This is excluded from reporting as therapeutic parenteral drug administration.
- Infiltration of a sustained release pharmacological agent for long-acting surgical site pain control.
  This sustained-release infiltration is not appropriate to report under therapeutic parenteral drug administration.
- Drug administration for cosmetic purposes (not a benefitted service).
  Cosmetic use is not benefitted.
Procedures considered experimental, investigational or unproven are not benefitted.
The name and dosage of the medication administered must be submitted for benefit consideration.
Medication name and dosage are required administrative elements.

Documentation Required

Clinical rationale and medication details required

Submit clinical chart notes/narrative explaining the rationale for the medication and include the name and dosage of the medication administered for benefit consideration.

D9610
D9612
D9613

Denial Risk

Excluded uses risk denial

Claims for administration of sedative/anesthetic/reversal agents, sustained-release infiltration for long-acting surgical site pain control, cosmetic drug administration, or procedures deemed experimental/investigational are not benefitted and may be denied.

D9613

Referenced codes

Referenced CDT Codes (informational)mixed

D9610	Therapeutic parenteral drug, single administration
D9612	Therapeutic parenteral drugs, two or more administrations, different medications
D9613	Infiltration of sustained release therapeutic drug single or multiple sites.

ICD-10-CM Diagnoses for Dental Diseases and ConditionsICD-10

No codes listed

Background & definitions

Therapeutic parenteral drug administration delivers medication via non-oral routes (intravenous, intramuscular, subcutaneous, intradermal) to allow rapid and precise drug absorption and to bypass the digestive system; it is indicated when oral or topical administration is ineffective, impractical, or too slow. This guidance applies to dental settings and covers therapeutic uses such as antibiotics, steroids, anti-inflammatory drugs or other medications intended to improve surgical healing, reduce pain and/or treat infection.

Guidance boundaries: Do not report therapeutic parenteral drug administration for the administration of sedative, anesthetic or reversal agents. Do not report it for the infiltration of a sustained-release pharmacological agent intended for long-acting surgical site pain control. Procedures considered experimental, investigational or unproven and drug administration for cosmetic purposes are not benefitted under this guidance. Clinical chart notes and a narrative may be requested, and the name and dosage of the medication administered must be submitted for benefit consideration.

Parenteral administration: Any technique in which the route of administration is intravenous, intramuscular, subcutaneous or intradermal.

Evidence & references

No clinical trial or formal evidence items were provided in this brief. The guidance is provided for informational purposes and does not constitute medical advice; federal/state law and contract language take precedence.

Policy revisions

2024-11-05clarified